[Federal Register: July 27, 2005 (Volume 70, Number 143)]
[Notices]
[Page 43455]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr27jy05-118]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances; Notice of Registration
By Notice dated April 11, 2005 and published in the Federal
Register on April 20, 2005 (70 FR 20600), Clinical Trial Services (US),
Inc., 2661 Audubon Road, Audubon, Pennsylvania 19403, made application
by renewal to the Drug Enforcement Administration (DEA) to be
registered as an importer of Fentanyl (9801), a basic class of
controlled substance listed in Schedule II.
The company plans to import small quantities of the listed
controlled substance in dosage form to conduct clinical trials.
No comments or objections have been received. DEA has considered
the factors in 21 U.S.C. 823(a) and 952(a) and determined that the
registration of Clinical Trial Services (US), Inc. to import the basic
class of controlled substance is consistent with the public interest
and with United States obligations under international treaties,
conventions, or protocols in effect on May 1, 1971, at this time. DEA
has investigated Clinical Trial Services (US), Inc. to ensure that the
company's registration is consistent with the public interest. The
investigation has included inspection and testing of the company's
physical security systems, verification of the company's compliance
with state and local laws, and a review of the company's background and
history. Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in
accordance with 21 CFR 1301.34, the above named company is granted
registration as an importer of the basic class of controlled substance
listed.
Dated: July 19, 2005.
William J. Walker,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 05-14825 Filed 7-26-05; 8:45 am]
BILLING CODE 4410-09-P